Incidence of Trimethoprim-Sulfamethoxazole-Resistant Enterobacteriaceae among Transplant Recipients
- 1 November 1984
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 150 (5), 699-706
- https://doi.org/10.1093/infdis/150.5.699
Abstract
Of 114 recipients of pancreatic, renal, and bone marrow transplants who were given trimethoprim-sulfamethoxazole (TMP-SMZ) for antimicrobial prophylaxis, 44 (39%) had a total of 52 fecal isolates of TMP-SMZ-resistant gram-negative bacilli. In most of these 44 patients, the resistant isolate was found at a concentration of ⩾106 organisms/ml of feces. Escherichia coli was the most frequent of the isolates, and Citrobacter freundii was the next most frequent. Eight of the 114 transplant recipients had gramnegative bacteremia; in six of these eight patients, a TMP-SMZ-resistant gram-negative bacillus was the etiologic agent of bacteremia. Four of the latter six patients had stool cultures analyzed prior to the detection of bacteremia; all four had high concentrations (⩾108/ml) of fecal TMP-SMZ-resistant E. coli one to 20 days before they were found to have E. coli bacteremia. In each of these instances, the E. coli isolates from the stool and the blood had similar antibiograms. These findings indicated that resistance to TMP-SMZ is becoming more prevalent and that the screening of patients for the presence of fecal TMP-SMZ-resistant Enterobacteriaceae prior to initiation of long-term therapy with this antimicrobial agent may be worthwhile.Keywords
This publication has 14 references indexed in Scilit:
- Oral antibiotic prophylaxis in patients with cancer: A double-blind randomized placebo-controlled trialThe Journal of Pediatrics, 1983
- Occurrence of transposable trimethoprim resistance in clinical isolates of Escherichia coli devoid of self-transmissible resistance plasmidsAntimicrobial Agents and Chemotherapy, 1982
- Emergence of High-Level Trimethoprim Resistance in FecalEscherichia coliduring Oral Administration of Trimethoprim or Trimethoprim-SulfamethoxazoleNew England Journal of Medicine, 1982
- Prevention of Infection by Trimethoprim-Sulfamethoxazole Plus Amphotericin B in Patients with Acute Nonlymphocytic LeukaemiaAnnals of Internal Medicine, 1981
- Selective suppression of alimentary tract microbial flora as prophylaxis during granulocytopeniaAntimicrobial Agents and Chemotherapy, 1981
- Deficiency of Intestinal Immunity with Graft-vs.-Host Disease in HumansThe Journal of Infectious Diseases, 1981
- Selective Antimicrobial Modulation of Human Microbial Flora: Infection Prevention in Patients with Decreased Host Defense Mechanisms by Selective Elimination of Potentially Pathogenic BacteriaThe Journal of Infectious Diseases, 1981
- Resistance among fecal flora of patients taking sulfamethoxazole-trimethoprim or trimethoprim aloneAntimicrobial Agents and Chemotherapy, 1981
- Distribution of Genes for Trimethoprim and Gentamicin Resistance in Bacteria and their Plasmids in a General HospitalMicrobiology, 1980
- EMERGENCE OF TRIMETHOPRIM-RESISTANT ENTEROBACTERIA IN PATIENTS RECEIVING LONG-TERM CO-TRIMOXAZOLE FOR THE CONTROL OF INTRACTABLE URINARY-TRACT INFECTIONThe Lancet, 1979